March 20, 2023
For World TB Day, TB Advocates Demand Universal Access to Shorter, Safer TB Regimens
Statement / Press
On March 24, World Tuberculosis (TB) Day offers an opportunity to take stock of global progress against the deadliest disease in human history. This year, we face a sobering reality: since the start of the COVID-19 pandemic, rates of TB infection and death are higher than they’ve been since the…

March 17, 2023
HIV Cure Research Information Sheet
Publication
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.

March 17, 2023
TAG Applauds Price Reduction of Molbio’s Truenat Diagnostics for Tuberculosis
Statement / Press
Treatment Action Group (TAG) applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostic tests for tuberculosis (TB) from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.

March 15, 2023
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

March 14, 2023
TB Vaccine Development: The Next Chapter Starts Now
Webinar / Presentation
On Thursday, April 13, join Treatment Action Group (TAG) for a webinar to learn more about important developments in TB vaccine research.

March 13, 2023
1 / 4 / 6 x 24
Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of…

March 8, 2023
Why Viral Load Can Be Detectable Despite Perfect Adherence
Webinar / Presentation
Webinar on March 22 that will provide an update on new research into cases in which the HIV reservoir generates detectable viral load that cannot be suppressed by antiretroviral therapy.

February 28, 2023
Open Letter: Urgent action necessary to improve equitable access to GeneXpert tuberculosis diagnostics and achieve 1/4/6×24
Letter / Comment
TAG and a coalition of civil society activists, public health leaders, and researchers acting in solidarity with communities affected by tuberculosis sent an open letter to Cepheid calling on the company to take urgent action necessary to improve equitable access to GeneXpert tuberculosis diagnostics and achieve 1/4/6×24.

February 24, 2023
Call for Expression of Interest: Community Advisory Boards to Support Community Engagement in Research under the SMART4TB Project
The SMART4TB Consortium is calling for expressions of interest from multi-national community advisory boards (CAB) or similarly organized civil society organizations within three geographic focus areas to support community engagement in research in a new five-year research project funded by USAID.

February 22, 2023
CROI 2023 Tuberculosis Research Round Up
Statement / Press
Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI).

February 17, 2023
TB Treatment Trial Results in Context for Communities
Webinar / Presentation
On Tuesday, March 14 at 8:00 am ET, join Treatment Action Group (TAG) and Dr. Jennifer Furin for an overview of key results and breakdown of how they fit into the larger TB policy and research landscapes.

February 10, 2023
2023 Pre-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2023 Pre-CROI Community HIV Cure Research Workshop will be held on Saturday, February 18th in the Sequoia Glacier Room at Crowne Plaza Hotel, 1113 – 6th Avenue, Seattle, WA 98101.

February 9, 2023
Treatment Action Group Announces Palm Desert Exhibition at Melissa Morgan Fine Art – “35 Years of Art to End AIDS”
Statement / Press
Treatment Action Group (TAG) is pleased to present the exhibition “35 Years of Art to End AIDS” at Melissa Morgan Fine Art in Palm Desert, CA. The exhibition features selected works from TAG’s Limited Art Editions Collection and will run from March 17 through April 7.

February 8, 2023
For Us By Us: PrEP in Black America
Publication
For Us By Us: PrEP in Black America, A Master Plan for HIV Prevention in Black America is a collaborative project from the PrEP in Black America coalition, which includes Treatment Action Group, PrEP4All, AVAC, Atlanta Black Women Leaders on PrEP, Equity & Impact Solutions, iStrive, Positive Impact Health Centers, and Red Hot.

February 2, 2023
The Power of PrEP
Webinar / Presentation
To mark National Black HIV/AIDS Awareness Day on February 7, Treatment Action Group (TAG) is co-hosting a webinar “The Power of PrEP” in coalition with PrEP4All, Atlanta Black Women, AVAC, and iStrive.

February 1, 2023
Community Call to Action on Equitable Access to Long-Acting Therapies
Statement / Press
The growing pipeline for long-acting therapies and their potential to accelerate various national and global disease elimination goals warrants global community mobilization to ensure equitable access to these therapies.

January 20, 2023
Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEPFAR COPs
Webinar / Presentation
On January 24, 2022, Treatment Action Group (TAG), World Hepatitis Alliance (WHA), Harm Reduction International (HRI), the International Network of People Who Use Drugs (INPUD), and the International Drug Policy Consortium (IDPC) will host a webinar, “Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use…

January 13, 2023
Open Letter: Urgent Action Necessary to Improve Equitable Access to Bedaquiline-Based Regimens and Achieve 1/4/6×24
Letter / Comment
TAG and a coalition of civil society activists, public health leaders, and researchers acting in solidarity with communities affected by tuberculosis sent an open letter to Johnson & Johnson calling on the company to publicly commit to withdraw and not enforce the fumarate salt patent claims and other secondary patents…

December 16, 2022
Treatment Action Group Resource on the Demographics of Participation in HIV Cure-Related Clinical Research
In 2014, TAG began tracking HIV cure-related trials and observational studies and making the information available as a listing on our website. The primary sources are online study registries, particularly the US-based clinicaltrials.gov.

December 15, 2022
Risk of Breakthrough COVID-19 Infections and Disease in Vaccinated People with HIV
Publication
This fact sheet on breakthrough COVID-19 infections among people living with HIV was co-produced by TAG and our partners the Black AIDS Institute, Southern AIDS Coalition and the COVID-19 Prevention Network.

December 8, 2022
2022 TAG Update
Publication
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

December 6, 2022
2022 Report on TB Research Funding Trends
TB R&D Report
For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021.

November 16, 2022
Response to Tuberculosis Treatment Trials Results Published and Presented During the 2022 Union World Conference on Lung Health
Statement / Press
Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB) welcome the clinical trials results recently published and presented during the 2022 Union World Conference on Lung Health, which evaluated shorter regimens and treatment shortening strategies for drug-sensitive and drug-resistant tuberculosis.

November 11, 2022
1/4/6×24 Community Campaign Training Materials
Publication
Community engagement and mobilization will be key to winning equitable access to the short-course treatment and prevention regimens at the heart of the 1/4/6×24 Campaign. For everyone to benefit from the scientific progress that made these effective new preventive treatments and cures possible, governments and other duty bearers and stakeholders…

November 10, 2022
Public Comment Submitted to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
Letter / Comment
Comment submitted prior to their meeting on November 17, 2022. Comment is in regard to discussion and voting on recommendation related to implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, specifically pertaining to HIV-positive to HIV-positive organ transplantation and pertaining to the following draft recommendation under consideration…